Fingerprint
Dive into the research topics of 'Phase 1 Dose Escalation Study of MEDI-565, a Bispecific T-Cell Engager that Targets Human Carcinoembryonic Antigen, in Patients With Advanced Gastrointestinal Adenocarcinomas'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically